The related parameters of cation size and valence that control the crystallization of Sr(3)CaRu(2)O(9) into a 1:2 B-site-ordered perovskite structure were explored by cationic substitution at the strontium and calcium sites and by the application of high pressure. At ambient pressures, Sr(3)MRu(2)O(9) stoichiometries yield multiphasic mixtures for M = Ni(2+), Mg(2+), and Y(3+), whereas pseudocubic perovskites result for M = Cu(2+) and Zn(2+). For A-site substitutions, an ordered perovskite structure results for Sr(3-x)Ca(x)CaRu(2)O(9), with 0 </= x </= 1.5. In contrast, Ba(2+) substitution for Sr(2+) is accompanied by a phase change to a hexagonal BaTiO(3) structure type. At high pressures and temperatures, a 1:2 B-site-ordered perovskite structure is stabilized for Sr(3-x)Ba(x)CaRu(2)O(9), with 0 </= x </= 3. The scarcity of B-site-ordered perovskite ruthenates at ambient pressure and the metastable nature of the high-pressure phases underscore the strict size and valence requirements that must be met by the constituent cations to achieve these uncommon ordered structures.
No takes yet. Share an insight, caveat, or question.
Rijssenbeek et al. (2004) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: